← Back to Clinical Trials
Recruiting NCT05764759

NCT05764759 Investigating Novel Smoking Cessation Primary Care Interventions in Rural Environments

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05764759
Status Recruiting
Phase
Sponsor Medical University of South Carolina
Condition Smoking Cessation
Study Type INTERVENTIONAL
Enrollment 288 participants
Start Date 2023-03-07
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Smoking cessation e-visitTreatment as usual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 288 participants in total. It began in 2023-03-07 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation across rural primary care settings. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to quit, and preferences for medications for quitting smoking. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.

Eligibility Criteria

Inclusion Criteria: * Current cigarette smoking, defined as smoking 1+ cigarettes per day, for 20+ days out of the last 30, for the last 6+ months * Age 18+ * Enrolled in Epic's MyChart program or willing to enroll * Possess a valid e-mail address that is checked daily to access study assessments and MyChart messages * Owner of an iOS or Android compatible smartphone to provide remote CO readings * Have a valid address at which mail can be received (for mailing iCO™) * English fluency Exclusion Criteria: \- Current engagement in cessation treatment, defined as use of an FDA-approved cessation medication within the last 7 days

Contact & Investigator

Central Contact

Noelle E Natale

✉ natalen@musc.edu

📞 843-876-9457

Frequently Asked Questions

Who can join the NCT05764759 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05764759 currently recruiting?

Yes, NCT05764759 is actively recruiting participants. Contact the research team at natalen@musc.edu for enrollment information.

Where is the NCT05764759 trial being conducted?

This trial is being conducted at Charleston, United States.

Who is sponsoring the NCT05764759 clinical trial?

NCT05764759 is sponsored by Medical University of South Carolina. The trial plans to enroll 288 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology